
    
      A maximum of 104 subjects will be enrolled across a maximum of 5 study sites in the United
      States.

      The estimated duration of the study is approximately 8 months from the time of first subject
      enrollment to the last subject enrollment. Enrollment occurs intraoperatively after
      confirmation of the intraoperative eligibility criteria. Subjects will undergo intraoperative
      performance assessments and then will be discontinued from the study after completion of the
      intraoperative visit.
    
  